Zoetis | ZTS - Assets



Zoetis reported $14.48B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
AbbVie USD 136.17B 1B Mar/2025
Align Technology USD 6.22B 116.27M Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Dentsply International USD 6.07B 19M Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Henry Schein USD 10.91B 426M Jun/2025
Idexx Laboratories USD 3.33B 117.1M Jun/2025
Illumina USD 6.09B 95M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Laboratory Of America USD 18.06B 456.1M Jun/2025
Merck USD 117.52B 2.4B Jun/2025
Neogen USD 3.44B 592.5M May/2025
Pacira USD 1.54B 49.41M Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Sanofi 124.96B 6.93B Jun/2025
Sanofi 124.96B 7.84B Jun/2025
Zoetis USD 14.48B 381M Jun/2025